Revenue Remaining Performance Obligation
Breakdown
Segments
Development Services For MonotherapyView metric
Development Services In Combination With Other TherapiesView metric
Commercialization ServicesView metric
| Segment | Q4 '25 | Q1 '26 |
|---|---|---|
| Commercialization Services | $272.6M | $275.7M |
| Development Services In Combination With Other Therapies | $167M | $161.7M |
| Development Services For Monotherapy | $34.3M | $27M |
| Total | $48.98M | $47.7M |